Global Pharmaceutical CXO Market Growth (Status and Outlook) 2021-2027


Jan, 2022 | Report ID: 218494 | 117 | Services

According to this latest study, the 2021 growth of Pharmaceutical CXO will have significant change from previous year. By the most conservative estimates of global Pharmaceutical CXO market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Pharmaceutical CXO market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2027.

This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical CXO market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2027 in section 10.7.

CRO

CMO

CDMO

Segmentation by end user: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2027 in section 10.8.

Pharmaceutical Companies

Biotechnology Companies

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

WuXi AppTec

Tigermed

Charles River Laboratories

Pharmaron Inc

Labcorp Drug Development

Boehringer Ingelheim

GenScript

MabPlex International

Shanghai ChemPartner

Wuxi Biologics

Pharmablock

Jiuzhou Pharma

Asym Chemical

IQVIA

Syneos Health

Parexel

AGC Biologics

FUJIFILM Diosynth Biotechnologies

Patheon

Catalent

Lonza Group AG

Avid Bioservices

AbbVie


Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Pharmaceutical CXO Market Size 2016-2026

2.1.2 Pharmaceutical CXO Market Size CAGR by Region 2020 VS 2021 VS 2026

2.2 Pharmaceutical CXO Segment by Type

2.2.1 CRO

2.2.2 CRO

2.2.3 CDMO

2.3 Pharmaceutical CXO Market Size by Type

2.3.1 Global Pharmaceutical CXO Market Size CAGR by Type

2.3.2 Global Pharmaceutical CXO Market Size Market Share by Type (2016-2021)

2.4 Pharmaceutical CXO Segment by End User

2.4.1 Pharmaceutical Companies

2.4.2 Biotechnology Companies

2.5 Pharmaceutical CXO Market Size by End User

2.5.1 Global Pharmaceutical CXO Market Size CAGR by End User

2.5.2 Global Pharmaceutical CXO Market Size Market Share by End User (2016-2021)

3 Pharmaceutical CXO Market Size by Players

3.1 Pharmaceutical CXO Market Size Market Share by Players

3.1.1 Global Pharmaceutical CXO Revenue by Players (2019-2021E)

3.1.2 Global Pharmaceutical CXO Revenue Market Share by Players (2019-2021E)

3.2 Global Pharmaceutical CXO Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Pharmaceutical CXO by Regions

4.1 Pharmaceutical CXO Market Size by Regions (2016-2021)

4.2 Americas Pharmaceutical CXO Market Size Growth (2016-2021)

4.3 APAC Pharmaceutical CXO Market Size Growth (2016-2021)

4.4 Europe Pharmaceutical CXO Market Size Growth (2016-2021)

4.5 Middle East & Africa Pharmaceutical CXO Market Size Growth (2016-2021)

5 Americas

5.1 Americas Pharmaceutical CXO Market Size by Country (2016-2021)

5.2 Americas Pharmaceutical CXO Market Size by Type (2016-2021)

5.3 Americas Pharmaceutical CXO Market Size by End User (2016-2021)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Pharmaceutical CXO Market Size by Region (2016-2021)

6.2 APAC Pharmaceutical CXO Market Size by Type (2016-2021)

6.3 APAC Pharmaceutical CXO Market Size by End User (2016-2021)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Pharmaceutical CXO by Country (2016-2021)

7.2 Europe Pharmaceutical CXO Market Size by Type (2016-2021)

7.3 Europe Pharmaceutical CXO Market Size by End User (2016-2021)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Pharmaceutical CXO by Region (2016-2021)

8.2 Middle East & Africa Pharmaceutical CXO Market Size by Type (2016-2021)

8.3 Middle East & Africa Pharmaceutical CXO Market Size by End User (2016-2021)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Global Pharmaceutical CXO Market Forecast

10.1 Global Pharmaceutical CXO Forecast by Regions (2021-2026)

10.1.1 Global Pharmaceutical CXO Forecast by Regions (2021-2026)

10.1.2 Americas Pharmaceutical CXO Forecast

10.1.3 APAC Pharmaceutical CXO Forecast

10.1.4 Europe Pharmaceutical CXO Forecast

10.1.5 Middle East & Africa Pharmaceutical CXO Forecast

10.2 Americas Pharmaceutical CXO Forecast by Countries (2021-2026)

10.2.1 United States Pharmaceutical CXO Market Forecast

10.2.2 Canada Pharmaceutical CXO Market Forecast

10.2.3 Mexico Pharmaceutical CXO Market Forecast

10.2.4 Brazil Pharmaceutical CXO Market Forecast

10.3 APAC Pharmaceutical CXO Forecast by Region (2021-2026)

10.3.1 China Pharmaceutical CXO Market Forecast

10.3.2 Japan Pharmaceutical CXO Market Forecast

10.3.3 Korea Pharmaceutical CXO Market Forecast

10.3.4 Southeast Asia Pharmaceutical CXO Market Forecast

10.3.5 India Pharmaceutical CXO Market Forecast

10.3.6 Australia Pharmaceutical CXO Market Forecast

10.4 Europe Pharmaceutical CXO Forecast by Country (2021-2026)

10.4.1 Germany Pharmaceutical CXO Market Forecast

10.4.2 France Pharmaceutical CXO Market Forecast

10.4.3 UK Pharmaceutical CXO Market Forecast

10.4.4 Italy Pharmaceutical CXO Market Forecast

10.4.5 Russia Pharmaceutical CXO Market Forecast

10.5 Middle East & Africa Pharmaceutical CXO Forecast by Region (2021-2026)

10.5.1 Egypt Pharmaceutical CXO Market Forecast

10.5.2 South Africa Pharmaceutical CXO Market Forecast

10.5.3 Israel Pharmaceutical CXO Market Forecast

10.5.4 Turkey Pharmaceutical CXO Market Forecast

10.5.5 GCC Countries Pharmaceutical CXO Market Forecast

10.6 Global Pharmaceutical CXO Forecast by Type (2021-2026)

10.7 Global Pharmaceutical CXO Forecast by End User (2021-2026)

11 Key Players Analysis

11.1 WuXi AppTec

11.1.1 WuXi AppTec Company Information

11.1.2 WuXi AppTec Pharmaceutical CXO Product Offered

11.1.3 WuXi AppTec Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)

11.1.4 WuXi AppTec Main Business Overview

11.1.5 WuXi AppTec Latest Developments

11.2 Tigermed

11.2.1 Tigermed Company Information

11.2.2 Tigermed Pharmaceutical CXO Product Offered

11.2.3 Tigermed Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)

11.2.4 Tigermed Main Business Overview

11.2.5 Tigermed Latest Developments

11.3 Charles River Laboratories

11.3.1 Charles River Laboratories Company Information

11.3.2 Charles River Laboratories Pharmaceutical CXO Product Offered

11.3.3 Charles River Laboratories Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)

11.3.4 Charles River Laboratories Main Business Overview

11.3.5 Charles River Laboratories Latest Developments

11.4 Pharmaron Inc

11.4.1 Pharmaron Inc Company Information

11.4.2 Pharmaron Inc Pharmaceutical CXO Product Offered

11.4.3 Pharmaron Inc Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)

11.4.4 Pharmaron Inc Main Business Overview

11.4.5 Pharmaron Inc Latest Developments

11.5 Labcorp Drug Development

11.5.1 Labcorp Drug Development Company Information

11.5.2 Labcorp Drug Development Pharmaceutical CXO Product Offered

11.5.3 Labcorp Drug Development Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)

11.5.4 Labcorp Drug Development Main Business Overview

11.5.5 Labcorp Drug Development Latest Developments

11.6 Boehringer Ingelheim

11.6.1 Boehringer Ingelheim Company Information

11.6.2 Boehringer Ingelheim Pharmaceutical CXO Product Offered

11.6.3 Boehringer Ingelheim Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)

11.6.4 Boehringer Ingelheim Main Business Overview

11.6.5 Boehringer Ingelheim Latest Developments

11.7 GenScript

11.7.1 GenScript Company Information

11.7.2 GenScript Pharmaceutical CXO Product Offered

11.7.3 GenScript Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)

11.7.4 GenScript Main Business Overview

11.7.5 GenScript Latest Developments

11.8 MabPlex International

11.8.1 MabPlex International Company Information

11.8.2 MabPlex International Pharmaceutical CXO Product Offered

11.8.3 MabPlex International Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)

11.8.4 MabPlex International Main Business Overview

11.8.5 MabPlex International Latest Developments

11.9 Shanghai ChemPartner

11.9.1 Shanghai ChemPartner Company Information

11.9.2 Shanghai ChemPartner Pharmaceutical CXO Product Offered

11.9.3 Shanghai ChemPartner Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)

11.9.4 Shanghai ChemPartner Main Business Overview

11.9.5 Shanghai ChemPartner Latest Developments

11.10 Wuxi Biologics

11.10.1 Wuxi Biologics Company Information

11.10.2 Wuxi Biologics Pharmaceutical CXO Product Offered

11.10.3 Wuxi Biologics Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)

11.10.4 Wuxi Biologics Main Business Overview

11.10.5 Wuxi Biologics Latest Developments

11. Pharmablock

11.11.1 Pharmablock Company Information

11.11.2 Pharmablock Pharmaceutical CXO Product Offered

11.11.3 Pharmablock Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)

11.11.4 Pharmablock Main Business Overview

11.11.5 Pharmablock Latest Developments

11.12 Jiuzhou Pharma

11.12.1 Jiuzhou Pharma Company Information

11.12.2 Jiuzhou Pharma Pharmaceutical CXO Product Offered

11.12.3 Jiuzhou Pharma Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)

11.12.4 Jiuzhou Pharma Main Business Overview

11.12.5 Jiuzhou Pharma Latest Developments

11.13 Asym Chemical

11.13.1 Asym Chemical Company Information

11.13.2 Asym Chemical Pharmaceutical CXO Product Offered

11.13.3 Asym Chemical Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)

11.13.4 Asym Chemical Main Business Overview

11.13.5 Asym Chemical Latest Developments

11.14 IQVIA

11.14.1 IQVIA Company Information

11.14.2 IQVIA Pharmaceutical CXO Product Offered

11.14.3 IQVIA Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)

11.14.4 IQVIA Main Business Overview

11.14.5 IQVIA Latest Developments

11.15 Syneos Health

11.15.1 Syneos Health Company Information

11.15.2 Syneos Health Pharmaceutical CXO Product Offered

11.15.3 Syneos Health Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)

11.15.4 Syneos Health Main Business Overview

11.15.5 Syneos Health Latest Developments

11.16 Parexel

11.16.1 Parexel Company Information

11.16.2 Parexel Pharmaceutical CXO Product Offered

11.16.3 Parexel Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)

11.16.4 Parexel Main Business Overview

11.16.5 Parexel Latest Developments

11.17 AGC Biologics

11.17.1 AGC Biologics Company Information

11.17.2 AGC Biologics Pharmaceutical CXO Product Offered

11.17.3 AGC Biologics Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)

11.17.4 AGC Biologics Main Business Overview

11.17.5 AGC Biologics Latest Developments

11.18 FUJIFILM Diosynth Biotechnologies

11.18.1 FUJIFILM Diosynth Biotechnologies Company Information

11.18.2 FUJIFILM Diosynth Biotechnologies Pharmaceutical CXO Product Offered

11.18.3 FUJIFILM Diosynth Biotechnologies Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)

11.18.4 FUJIFILM Diosynth Biotechnologies Main Business Overview

11.18.5 FUJIFILM Diosynth Biotechnologies Latest Developments

11.19 Patheon

11.19.1 Patheon Company Information

11.19.2 Patheon Pharmaceutical CXO Product Offered

11.19.3 Patheon Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)

11.19.4 Patheon Main Business Overview

11.19.5 Patheon Latest Developments

11.20 Catalent

11.20.1 Catalent Company Information

11.20.2 Catalent Pharmaceutical CXO Product Offered

11.20.3 Catalent Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)

11.20.4 Catalent Main Business Overview

11.20.5 Catalent Latest Developments

11.21 Lonza Group AG

11.21.1 Lonza Group AG Company Information

11.21.2 Lonza Group AG Pharmaceutical CXO Product Offered

11.21.3 Lonza Group AG Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)

11.21.4 Lonza Group AG Main Business Overview

11.21.5 Lonza Group AG Latest Developments

11.22 Avid Bioservices

11.22.1 Avid Bioservices Company Information

11.22.2 Avid Bioservices Pharmaceutical CXO Product Offered

11.22.3 Avid Bioservices Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)

11.22.4 Avid Bioservices Main Business Overview

11.22.5 Avid Bioservices Latest Developments

11.23 AbbVie

11.23.1 AbbVie Company Information

11.23.2 AbbVie Pharmaceutical CXO Product Offered

11.23.3 AbbVie Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)

11.23.4 AbbVie Main Business Overview

11.23.5 AbbVie Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Pharmaceutical CXO Market Size CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of CRO

Table 3. Major Players of CMO

Table 4. Major Players of CDMO

Table 5. Pharmaceutical CXO Market Size CAGR by Type (2020-2026) & ($ Millions)

Table 6. Global Pharmaceutical CXO Market Size by Type (2016-2021) & ($ Millions)

Table 7. Global Pharmaceutical CXO Market Size Market Share by Type (2016-2021)

Table 8. Pharmaceutical CXO Market Size CAGR by End User (2016-2021) & ($ Millions)

Table 9. Global Pharmaceutical CXO Market Size by End User (2016-2021) & ($ Millions)

Table 10. Global Pharmaceutical CXO Market Size Market Share by End User (2016-2021)

Table 11. Global Pharmaceutical CXO Revenue by Players (2019-2021E) & ($ Millions)

Table 12. Global Pharmaceutical CXO Revenue Market Share by Players (2019-2021E)

Table 13. Pharmaceutical CXO Key Players Head office and Products Offered

Table 14. Pharmaceutical CXO Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)

Table 15. New Products and Potential Entrants

Table 16. Mergers & Acquisitions, Expansion

Table 17. Global Pharmaceutical CXO Market Size by Regions 2016-2021 & ($ Millions)

Table 18. Global Pharmaceutical CXO Market Size Market Share by Regions 2016-2021

Table 19. Americas Pharmaceutical CXO Market Size by Country (2016-2021) & ($ Millions)

Table 20. Americas Pharmaceutical CXO Market Size Market Share by Country (2016-2021)

Table 21. Americas Pharmaceutical CXO Market Size by Type (2016-2021) & ($ Millions)

Table 22. Americas Pharmaceutical CXO Market Size Market Share by Type (2016-2021)

Table 23. Americas Pharmaceutical CXO Market Size by End User (2016-2021) & ($ Millions)

Table 24. Americas Pharmaceutical CXO Market Size Market Share by End User (2016-2021)

Table 25. APAC Pharmaceutical CXO Market Size by Region (2016-2021) & ($ Millions)

Table 26. APAC Pharmaceutical CXO Market Size Market Share by Region (2016-2021)

Table 27. APAC Pharmaceutical CXO Market Size by Type (2016-2021) & ($ Millions)

Table 28. APAC Pharmaceutical CXO Market Size Market Share by Type (2016-2021)

Table 29. APAC Pharmaceutical CXO Market Size by End User (2016-2021) & ($ Millions)

Table 30. APAC Pharmaceutical CXO Market Size Market Share by End User (2016-2021)

Table 31. Europe Pharmaceutical CXO Market Size by Country (2016-2021) & ($ Millions)

Table 32. Europe Pharmaceutical CXO Market Size Market Share by Country (2016-2021)

Table 33. Europe Pharmaceutical CXO Market Size by Type (2016-2021) & ($ Millions)

Table 34. Europe Pharmaceutical CXO Market Size Market Share by Type (2016-2021)

Table 35. Europe Pharmaceutical CXO Market Size by End User (2016-2021) & ($ Millions)

Table 36. Europe Pharmaceutical CXO Market Size Market Share by End User (2016-2021)

Table 37. Middle East & Africa Pharmaceutical CXO Market Size by Region (2016-2021) & ($ Millions)

Table 38. Middle East & Africa Pharmaceutical CXO Market Size Market Share by Region (2016-2021)

Table 39. Middle East & Africa Pharmaceutical CXO Market Size by Type (2016-2021) & ($ Millions)

Table 40. Middle East & Africa Pharmaceutical CXO Market Size Market Share by Type (2016-2021)

Table 41. Middle East & Africa Pharmaceutical CXO Market Size by End User (2016-2021) & ($ Millions)

Table 42. Middle East & Africa Pharmaceutical CXO Market Size Market Share by End User (2016-2021)

Table 43. Key and Potential Regions of Pharmaceutical CXO

Table 44. Key Application and Potential Industries of Pharmaceutical CXO

Table 45. Key Challenges of Pharmaceutical CXO

Table 46. Key Trends of Pharmaceutical CXO

Table 47. Global Pharmaceutical CXO Market Size Forecast by Regions (2021-2026) & ($ Millions)

Table 48. Global Pharmaceutical CXO Market Size Market Share Forecast by Regions (2021-2026)

Table 49. Global Pharmaceutical CXO Market Size Forecast by Type (2021-2026) & ($ Millions)

Table 50. Global Pharmaceutical CXO Market Size Market Share Forecast by Type (2021-2026)

Table 51. Global Pharmaceutical CXO Market Size Forecast by End User (2021-2026) & ($ Millions)

Table 52. Global Pharmaceutical CXO Market Size Market Share Forecast by End User (2021-2026)

Table 53. WuXi AppTec Details, Company Type, Pharmaceutical CXO Area Served and Its Competitors

Table 54. WuXi AppTec Pharmaceutical CXO Product Offered

Table 55. WuXi AppTec Pharmaceutical CXO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 56. WuXi AppTec Main Business

Table 57. WuXi AppTec Latest Developments

Table 58. Tigermed Details, Company Type, Pharmaceutical CXO Area Served and Its Competitors

Table 59. Tigermed Pharmaceutical CXO Product Offered

Table 60. Tigermed Main Business

Table 61. Tigermed Pharmaceutical CXO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 62. Tigermed Latest Developments

Table 63. Charles River Laboratories Details, Company Type, Pharmaceutical CXO Area Served and Its Competitors

Table 64. Charles River Laboratories Pharmaceutical CXO Product Offered

Table 65. Charles River Laboratories Main Business

Table 66. Charles River Laboratories Pharmaceutical CXO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 67. Charles River Laboratories Latest Developments

Table 68. Pharmaron Inc Details, Company Type, Pharmaceutical CXO Area Served and Its Competitors

Table 69. Pharmaron Inc Pharmaceutical CXO Product Offered

Table 70. Pharmaron Inc Main Business

Table 71. Pharmaron Inc Pharmaceutical CXO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 72. Pharmaron Inc Latest Developments

Table 73. Labcorp Drug Development Details, Company Type, Pharmaceutical CXO Area Served and Its Competitors

Table 74. Labcorp Drug Development Pharmaceutical CXO Product Offered

Table 75. Labcorp Drug Development Main Business

Table 76. Labcorp Drug Development Pharmaceutical CXO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 77. Labcorp Drug Development Latest Developments

Table 78. Boehringer Ingelheim Details, Company Type, Pharmaceutical CXO Area Served and Its Competitors

Table 79. Boehringer Ingelheim Pharmaceutical CXO Product Offered

Table 80. Boehringer Ingelheim Main Business

Table 81. Boehringer Ingelheim Pharmaceutical CXO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 82. Boehringer Ingelheim Latest Developments

Table 83. GenScript Details, Company Type, Pharmaceutical CXO Area Served and Its Competitors

Table 84. GenScript Pharmaceutical CXO Product Offered

Table 85. GenScript Main Business

Table 86. GenScript Pharmaceutical CXO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 87. GenScript Latest Developments

Table 88. MabPlex International Details, Company Type, Pharmaceutical CXO Area Served and Its Competitors

Table 89. MabPlex International Pharmaceutical CXO Product Offered

Table 90. MabPlex International Main Business

Table 91. MabPlex International Pharmaceutical CXO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 92. MabPlex International Latest Developments

Table 93. Shanghai ChemPartner Details, Company Type, Pharmaceutical CXO Area Served and Its Competitors

Table 94. Shanghai ChemPartner Pharmaceutical CXO Product Offered

Table 95. Shanghai ChemPartner Main Business

Table 96. Shanghai ChemPartner Pharmaceutical CXO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 97. Shanghai ChemPartner Latest Developments

Table 98. Wuxi Biologics Details, Company Type, Pharmaceutical CXO Area Served and Its Competitors

Table 99. Wuxi Biologics Pharmaceutical CXO Product Offered

Table 100. Wuxi Biologics Main Business

Table 101. Wuxi Biologics Pharmaceutical CXO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 102. Wuxi Biologics Latest Developments

Table 103. Pharmablock Details, Company Type, Pharmaceutical CXO Area Served and Its Competitors

Table 104. Pharmablock Pharmaceutical CXO Product Offered

Table 105. Pharmablock Pharmaceutical CXO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 106. Pharmablock Main Business

Table 107. Pharmablock Latest Developments

Table 108. Jiuzhou Pharma Details, Company Type, Pharmaceutical CXO Area Served and Its Competitors

Table 109. Jiuzhou Pharma Pharmaceutical CXO Product Offered

Table 110. Jiuzhou Pharma Main Business

Table 111. Jiuzhou Pharma Pharmaceutical CXO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 112. Jiuzhou Pharma Latest Developments

Table 113. Asym Chemical Details, Company Type, Pharmaceutical CXO Area Served and Its Competitors

Table 114. Asym Chemical Pharmaceutical CXO Product Offered

Table 115. Asym Chemical Main Business

Table 116. Asym Chemical Pharmaceutical CXO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 117. Asym Chemical Latest Developments

Table 118. IQVIA Details, Company Type, Pharmaceutical CXO Area Served and Its Competitors

Table 119. IQVIA Pharmaceutical CXO Product Offered

Table 120. IQVIA Main Business

Table 121. IQVIA Pharmaceutical CXO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 122. IQVIA Latest Developments

Table 123. Syneos Health Details, Company Type, Pharmaceutical CXO Area Served and Its Competitors

Table 124. Syneos Health Pharmaceutical CXO Product Offered

Table 125. Syneos Health Main Business

Table 126. Syneos Health Pharmaceutical CXO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 127. Syneos Health Latest Developments

Table 128. Parexel Details, Company Type, Pharmaceutical CXO Area Served and Its Competitors

Table 129. Parexel Pharmaceutical CXO Product Offered

Table 130. Parexel Main Business

Table 131. Parexel Pharmaceutical CXO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 132. Parexel Latest Developments

Table 133. AGC Biologics Details, Company Type, Pharmaceutical CXO Area Served and Its Competitors

Table 134. AGC Biologics Pharmaceutical CXO Product Offered

Table 135. AGC Biologics Main Business

Table 136. AGC Biologics Pharmaceutical CXO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 137. AGC Biologics Latest Developments

Table 138. FUJIFILM Diosynth Biotechnologies Details, Company Type, Pharmaceutical CXO Area Served and Its Competitors

Table 139. FUJIFILM Diosynth Biotechnologies Pharmaceutical CXO Product Offered

Table 140. FUJIFILM Diosynth Biotechnologies Main Business

Table 141. FUJIFILM Diosynth Biotechnologies Pharmaceutical CXO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 142. FUJIFILM Diosynth Biotechnologies Latest Developments

Table 143. Patheon Details, Company Type, Pharmaceutical CXO Area Served and Its Competitors

Table 144. Patheon Pharmaceutical CXO Product Offered

Table 145. Patheon Main Business

Table 146. Patheon Pharmaceutical CXO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 147. Patheon Latest Developments

Table 148. Catalent Details, Company Type, Pharmaceutical CXO Area Served and Its Competitors

Table 149. Catalent Pharmaceutical CXO Product Offered

Table 150. Catalent Main Business

Table 151. Catalent Pharmaceutical CXO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 152. Catalent Latest Developments

Table 153. Lonza Group AG Details, Company Type, Pharmaceutical CXO Area Served and Its Competitors

Table 154. Lonza Group AG Pharmaceutical CXO Product Offered

Table 155. Lonza Group AG Pharmaceutical CXO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 156. Lonza Group AG Main Business

Table 157. Lonza Group AG Latest Developments

Table 158. Avid Bioservices Details, Company Type, Pharmaceutical CXO Area Served and Its Competitors

Table 159. Avid Bioservices Pharmaceutical CXO Product Offered

Table 160. Avid Bioservices Main Business

Table 161. Avid Bioservices Pharmaceutical CXO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 162. Avid Bioservices Latest Developments

Table 163. AbbVie Details, Company Type, Pharmaceutical CXO Area Served and Its Competitors

Table 164. AbbVie Pharmaceutical CXO Product Offered

Table 165. AbbVie Main Business

Table 166. AbbVie Pharmaceutical CXO Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 167. AbbVie Latest Developments

List of Figures

Figure 1. Pharmaceutical CXO Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Pharmaceutical CXO Market Size Growth Rate 2016-2026 ($ Millions)

Figure 6. Global Pharmaceutical CXO Market Size Market Share by Type in 2020

Figure 7. Pharmaceutical CXO in Pharmaceutical Companies

Figure 8. Global Pharmaceutical CXO Market: Pharmaceutical Companies (2016-2021) & ($ Millions)

Figure 9. Pharmaceutical CXO in Biotechnology Companies

Figure 10. Global Pharmaceutical CXO Market: Biotechnology Companies (2016-2021) & ($ Millions)

Figure 11. Global Pharmaceutical CXO Market Size Market Share by End User in 2020

Figure 12. Global Pharmaceutical CXO Revenue Market Share by Player in 2020

Figure 13. Global Pharmaceutical CXO Market Size Market Share by Regions (2016-2021)

Figure 14. Americas Pharmaceutical CXO Market Size 2016-2021 ($ Millions)

Figure 15. APAC Pharmaceutical CXO Market Size 2016-2021 ($ Millions)

Figure 16. Europe Pharmaceutical CXO Market Size 2016-2021 ($ Millions)

Figure 17. Middle East & Africa Pharmaceutical CXO Market Size 2016-2021 ($ Millions)

Figure 18. Americas Pharmaceutical CXO Market Size Market Share by Country in 2020

Figure 19. Americas Pharmaceutical CXO Market Size Market Share by Type in 2020

Figure 20. Americas Pharmaceutical CXO Market Size Market Share by End User in 2020

Figure 21. United States Pharmaceutical CXO Market Size Growth 2016-2021 ($ Millions)

Figure 22. Canada Pharmaceutical CXO Market Size Growth 2016-2021 ($ Millions)

Figure 23. Mexico Pharmaceutical CXO Market Size Growth 2016-2021 ($ Millions)

Figure 24. APAC Pharmaceutical CXO Market Size Market Share by Regions in 2020

Figure 25. APAC Pharmaceutical CXO Market Size Market Share by Type in 2020

Figure 26. APAC Pharmaceutical CXO Market Size Market Share by End User in 2020

Figure 27. China Pharmaceutical CXO Market Size Growth 2016-2021 ($ Millions)

Figure 28. Japan Pharmaceutical CXO Market Size Growth 2016-2021 ($ Millions)

Figure 29. Korea Pharmaceutical CXO Market Size Growth 2016-2021 ($ Millions)

Figure 30. Southeast Asia Pharmaceutical CXO Market Size Growth 2016-2021 ($ Millions)

Figure 31. India Pharmaceutical CXO Market Size Growth 2016-2021 ($ Millions)

Figure 32. Australia Pharmaceutical CXO Market Size Growth 2016-2021 ($ Millions)

Figure 33. Europe Pharmaceutical CXO Market Size Market Share by Country in 2020

Figure 34. Europe Pharmaceutical CXO Market Size Market Share by Type in 2020

Figure 35. Europe Pharmaceutical CXO Market Size Market Share by End User in 2020

Figure 36. Germany Pharmaceutical CXO Market Size Growth 2016-2021 ($ Millions)

Figure 37. France Pharmaceutical CXO Market Size Growth 2016-2021 ($ Millions)

Figure 38. UK Pharmaceutical CXO Market Size Growth 2016-2021 ($ Millions)

Figure 39. Italy Pharmaceutical CXO Market Size Growth 2016-2021 ($ Millions)

Figure 40. Russia Pharmaceutical CXO Market Size Growth 2016-2021 ($ Millions)

Figure 41. Middle East & Africa Pharmaceutical CXO Market Size Market Share by Region in 2020

Figure 42. Middle East & Africa Pharmaceutical CXO Market Size Market Share by Type in 2020

Figure 43. Middle East & Africa Pharmaceutical CXO Market Size Market Share by End User in 2020

Figure 44. Egypt Pharmaceutical CXO Market Size Growth 2016-2021 ($ Millions)

Figure 45. South Africa Pharmaceutical CXO Market Size Growth 2016-2021 ($ Millions)

Figure 46. Israel Pharmaceutical CXO Market Size Growth 2016-2021 ($ Millions)

Figure 47. Turkey Pharmaceutical CXO Market Size Growth 2016-2021 ($ Millions)

Figure 48. GCC Country Pharmaceutical CXO Market Size Growth 2016-2021 ($ Millions)

Figure 49. Americas Pharmaceutical CXO Market Size 2021-2026 ($ Millions)

Figure 50. APAC Pharmaceutical CXO Market Size 2021-2026 ($ Millions)

Figure 51. Europe Pharmaceutical CXO Market Size 2021-2026 ($ Millions)

Figure 52. Middle East & Africa Pharmaceutical CXO Market Size 2021-2026 ($ Millions)

Figure 53. United States Pharmaceutical CXO Market Size 2021-2026 ($ Millions)

Figure 54. Canada Pharmaceutical CXO Market Size 2021-2026 ($ Millions)

Figure 55. Mexico Pharmaceutical CXO Market Size 2021-2026 ($ Millions)

Figure 56. Brazil Pharmaceutical CXO Market Size 2021-2026 ($ Millions)

Figure 57. China Pharmaceutical CXO Market Size 2021-2026 ($ Millions)

Figure 58. Japan Pharmaceutical CXO Market Size 2021-2026 ($ Millions)

Figure 59. Korea Pharmaceutical CXO Market Size 2021-2026 ($ Millions)

Figure 60. Southeast Asia Pharmaceutical CXO Market Size 2021-2026 ($ Millions)

Figure 61. India Pharmaceutical CXO Market Size 2021-2026 ($ Millions)

Figure 62. Australia Pharmaceutical CXO Market Size 2021-2026 ($ Millions)

Figure 63. Germany Pharmaceutical CXO Market Size 2021-2026 ($ Millions)

Figure 64. France Pharmaceutical CXO Market Size 2021-2026 ($ Millions)

Figure 65. UK Pharmaceutical CXO Market Size 2021-2026 ($ Millions)

Figure 66. Italy Pharmaceutical CXO Market Size 2021-2026 ($ Millions)

Figure 67. Russia Pharmaceutical CXO Market Size 2021-2026 ($ Millions)

Figure 68. Spain Pharmaceutical CXO Market Size 2021-2026 ($ Millions)

Figure 69. Egypt Pharmaceutical CXO Market Size 2021-2026 ($ Millions)

Figure 70. South Africa Pharmaceutical CXO Market Size 2021-2026 ($ Millions)

Figure 71. Israel Pharmaceutical CXO Market Size 2021-2026 ($ Millions)

Figure 72. Turkey Pharmaceutical CXO Market Size 2021-2026 ($ Millions)

Figure 73. GCC Country Pharmaceutical CXO Market Size 2021-2026 ($ Millions)

Sample Request is not available